Dr. Reddy’s arm receives USFDA approval for Sernivo Spray

08 Feb 2016 Evaluate

Dr. Reddy’s Laboratories’ US subsidiary, Promius Pharma, LLC, US, has received approval for Sernivo (betamethasone dipropionate) Spray, 0.05% from the US Food and Drug Administration (USFDA). Sernivo Spray, a prescription topical steroid, is indicated for the treatment of mild to moderate plaque psoriasis in patients 18 years of age or older. The commercial launch of the product is planned for the coming quarter.

Dr. Reddy's Laboratories, is a multinational pharmaceutical company based in Hyderabad, Telangana in India. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas.


Dr. Reddys Lab Share Price

1166.75 -0.15 (-0.01%)
21-Jan-2026 12:25 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1618.30
Dr. Reddys Lab 1166.75
Cipla 1374.95
Zydus Lifesciences 880.25
Lupin 2162.85
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×